Physician profile
Dillon Warning
NPI 1144912130
$1,026.66
in general payments reported to CMS, 2019-2025
17 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $61.99 · 2024: $590 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.66 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $190.51 | 2024-2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $114.37 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Urogen Pharma, INC. | $97.03 | 2024-2025 | |
| Boston Scientific Corporation | $84.94 | 2024 | |
| Teleflex LLC | $79.14 | 2024-2025 | Urolift |
| Sumitomo Pharma America, INC. | $74.96 | 2023-2025 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $68.26 | 2024 | |
| Endo USA, INC. | $50.40 | 2025 | Aveed, Xiaflex |
| Abbvie INC. | $50.36 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $44.65 | 2024-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $34.54 | 2024 | Provenge |
| Civco Medical Instruments | $28.76 | 2024 | |
| Antares Pharma, INC. | $26.50 | 2025 | Xyosted |
| Halozyme INC | $25.53 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.45 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $19.17 | 2024 | Aveed, Xiaflex |
| Laborie Medical Technologies Corp. | $14.09 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillon Warning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.